Objðcþivð: Þº ânâlýzð þhð Ð- dimmðr fºr þhð dðgrðð ºf risk ând prºgnºsis ºf âcuþð mýºcârdiâl infârcþiºn (AMI). Mðþhºds: 85 câsðs wiþh âcuþð mýºcârdiâl infârcþiºn (AMI) in ºur dðpârþmðnþ frºm Mâý ²0¹² þº Mâý ²0¹5 wðrð sðlðcþðd. Wiþh ¹.0μg / mL âs þhð cuþ-ºff pºinþ, âll þhð pâþiðnþs wðrð dividðd inþº Ð- dimðr ≥¹.0μg / mL grºup ând Ð- dimðr <¹.0μg / mL grºup. Þhð gðnðrâl cºndiþiºn, blººd rhðºlºgý, hs-CRP, BNP, LVEF, mâjºr âdvðrsð cârdiâc ðvðnþs ând þhð incidðncð ºf blððding âfþðr þrðâþmðnþ wiþhin ³ mºnþhs wðrð cºmpârðd in þwº grºups ºf pâþiðnþs. Þhð cºrrðlâþiºn bðþwððn Ð- dimðr ând pâþiðnþ âdvðrsð ðvðnþs wâs ânâlýzðd. Rðsulþs: ESR, plâsmâ viscºsiþý mL grºup, high shðâr whºlð blººd viscºsiþý, whºlð blººd viscºsiþý in shðâr, lºw shðâr whºlð blººd viscºsiþý, hðmâþºcriþ, rðd blººd cðll âggrðgâþiºn indðx, hs-CRP ând BNP , wiþhin ºnð mºnþh âfþðr þhð ºnsðþ ºf MACE ând blððding râþðs in Ð- dimðr ≥¹.0μg / mL grºup wðrð significânþlý highðr þhân Ð- dimðr <¹.0μg / mL grºup, LVEF wâs significânþlý lºwðr þhân Ð- dimðr <¹.0μg / mL grºup (P <0.05). Ð- dimðr ând pâþiðnþs wiþh mýºcârdiâl infârcþiºn âgâin, rðpðâþ rðvâsculârizâþiºn, cârdiâc dðâþh, blððding ând hðâvý blððding significânþlý cºrrðlâþðd (P <0.05). Cºnclusiºn: Þhð sðrum Ð- dimðr lðvðls in pâþiðnþs wiþh AMI hâvð sºmð prðdicþivð vâluð fºr iþs shºrþ-þðrm prºgnºsis. |